Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 20/20 | 0.45 |
| ▸ | UGCG | Q16739 | 20/20 | 0.45 |
| ▸ | GBA2 | Q9HCG7 | 20/20 | 0.45 |
| ▸ | LCT | P09848 | 9/20 | 0.45 |
| ▸ | SI | P14410 | 6/20 | 0.45 |
| ▸ | MGAM | O43451 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26219600 | 0.95 | UGCG (0.49) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL26219247 | 0.84 | UGCG (0.64) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL26219281 | 0.80 | UGCG (0.68) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL26219527 | 0.80 | UGCG (0.68) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL25962343 | 0.79 | GBA1 (0.51) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL26219481 | 0.76 | UGCG (0.66) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL25962193 | 0.71 | UGCG (0.73) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL26022347 | 0.70 | UGCG (0.71) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL26219187 | 0.70 | UGCG (0.65) | GBA1UGCGGBA2LCTSI | |
| SCHEMBL25962213 | 0.69 | UGCG (0.67) | GBA1UGCGGBA2LCTSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4209215-A1 | TREATMENT OF GM2 GANGLIOSIDOSIS | Azafaros B.V. (NL) | 2023-07-12 | — | — | EP | disclosed |